Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Other Accumulated Expenses (2016)

STRATA Skin Sciences (SSKN) has disclosed Other Accumulated Expenses for 5 consecutive years, with $1000.0 as the latest value for Q2 2016.

  • Quarterly Other Accumulated Expenses changed N/A to $1000.0 in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $1000.0 through Jun 2016, changed N/A year-over-year, with the annual reading at $234000.0 for FY2014, 244.12% up from the prior year.
  • Other Accumulated Expenses hit $1000.0 in Q2 2016 for STRATA Skin Sciences, down from $13000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $778000.0 in Q3 2015 to a low of $1000.0 in Q2 2016.
  • Historically, Other Accumulated Expenses has averaged $118433.2 across 5 years, with a median of $60596.0 in 2013.
  • Biggest five-year swings in Other Accumulated Expenses: fell 29.39% in 2013 and later surged 480.29% in 2015.
  • Year by year, Other Accumulated Expenses stood at $41000.0 in 2012, then soared by 65.85% to $68000.0 in 2013, then soared by 244.12% to $234000.0 in 2014, then soared by 232.48% to $778000.0 in 2015, then crashed by 99.87% to $1000.0 in 2016.
  • Business Quant data shows Other Accumulated Expenses for SSKN at $1000.0 in Q2 2016, $13000.0 in Q1 2016, and $778000.0 in Q3 2015.